• Home>
  • Stocks>
  • J B Chemicals & Pharmaceuticals Ltd Share Price
J B Chemicals & Pharmaceuticals Ltd share price logo

J B Chemicals & Pharmaceuticals Ltd Share Price (JBCHEPHARM)

₹1716.70.07%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

J B Chemicals & Pharmaceuticals Ltd Stock Performance

as on August 14, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹1,701.4
    ₹1,729
    downward going graph

    0.89%

    Downside

    0.72%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹1,385.75
    ₹2,030
    downward going graph

    19.28%

    Downside

    18.25%

    Upside

    downward going graph
Previous Close₹1,715.50
Open₹1,725.00
Volume74.24K
Upper Circuit₹2,058.60
Lower Circuit₹1,372.40
Day's Low1,701.4
Day's High1,729
52 Week Low1,385.75
52 Week High2,030
1 Month Return+ 3.72 %
3 Month Return+ 4.22 %
1 Year Return-12.7 %
3 Year Return+ 84.09 %
5 Year Return+ 341.9 %

J B Chemicals & Pharmaceuticals Ltd Stock Fundamentals & Key Indicators

Check J B Chemicals & Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹26,835.11 Cr

Return on Equity (ROE)

20.84

PE Ratio (TTM)

38.97

Return on capital employed (ROCE)

26.54

Industry PE ratio

43.28

Beta (LTM)

0.64

P/B Ratio

7.48

Dividend Yield

0.96

PEG Ratio

6.39

Quarterly Earnings Growth YOY

14.45

EPS (TTM)

42.37

Sector

Pharmaceuticals

Book Value

220.54

Technical Analysis

J B Chemicals & Pharmaceuticals Ltd Stock's Interest Amongst Investors

-46%

Period Aug 18, 2025 to Jul 19, 2025. Change in 30 Days vs previous period

Search interest for J B Chemicals & Pharmaceuticals Ltd Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.

J B Chemicals & Pharmaceuticals Ltd Stock Valuation

Track how J B Chemicals & Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.

J B Chemicals & Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (10.61x)

October 24, 2019

Today (38.97x)

August 14, 2025

Industry (43.28x)

August 14, 2025

Highest (62.92x)

February 7, 2024

LowHigh

Today’s Price to Earnings Ratio: 38.97x

J B Chemicals & Pharmaceuticals Ltd Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on J B Chemicals & Pharmaceuticals Ltd.

based on 12 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

75% of analysts recommend a 'BUY' rating for J B Chemicals & Pharmaceuticals Ltd. Average target price of ₹2019.08

Source: S&P Global Market Intelligence

J B Chemicals & Pharmaceuticals Ltd Share Price Target

Get share price movements and forecasts by analysts on J B Chemicals & Pharmaceuticals Ltd.

J B Chemicals & Pharmaceuticals Ltd price forecast by 12 analysts

Upside of17.61%

High

₹2458

Target

₹2019.08

Low

₹1752

J B Chemicals & Pharmaceuticals Ltd target price ₹2019.08, a slight upside of 17.61% compared to current price of ₹1716.7. According to 12 analysts rating.

Source: S&P Global Market Intelligence

J B Chemicals & Pharmaceuticals Ltd Financial Results

Get the annual and quarterly financial summary of J B Chemicals & Pharmaceuticals Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

1004 (0%)1001 (0%)963 (4%)949 (1%)1094 (15%)
Net Income

(in ₹ Cr)

177 (0%)175 (1%)162 (7%)146 (10%)202 (39%)
Net Profit Margin17.61% (0%)17.45% (1%)16.86% (3%)15.34% (9%)18.50% (21%)
Value in ₹ crore
DetailsFY22FY23FY24FY25
Total Assets

(in ₹ Cr)

2620 (0%)3565 (36%)4011 (12%)4297 (7%)
Total Liabilities

(in ₹ Cr)

486 (0%)1085 (123%)1087 (0%)863 (21%)
Value in ₹ crore
DetailsFY21FY22FY23FY24FY25
Operating Cash Flow

(in ₹ Cr)

335 (0%)147 (56%)629 (327%)789 (26%)884 (12%)

J B Chemicals & Pharmaceuticals Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of J B Chemicals & Pharmaceuticals Ltd.

  • J B Chemicals & Pharmaceuticals Ltd Earnings Results

    J B Chemicals & Pharmaceuticals Ltd’s net profit jumped 14.45% since last year same period to ₹202.38Cr in the Q1 2025-2026. On a quarterly growth basis, J B Chemicals & Pharmaceuticals Ltd has generated 38.91% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • J B Chemicals & Pharmaceuticals Ltd Dividends May,2025

    In the quarter ending March 2025, J B Chemicals & Pharmaceuticals Ltd has declared dividend of ₹7.00 per share on 14 May 2025 - translating a dividend yield of 1.30%.

    Read More about Dividends

Indices Featuring J B Chemicals & Pharmaceuticals Ltd Stock

Check stock indices that include J B Chemicals & Pharmaceuticals Ltd.

S&P BSE SmallCap Select

₹7,854.95

-0.58 (-45.89%)

NIFTY PHARMA

₹22,151.85

0.1 (21.55%)

Nifty Smallcap 250

₹16,656.75

-0.43 (-71.15%)

BSE 500

₹35,604.49

-0.08 (-27.42%)

Nifty MidSmallcap 400

₹19,454.20

-0.3 (-59.35%)

BSE Small-Cap

₹51,788.88

-0.59 (-306.96%)

Nifty 500

₹22,680.25

-0.08 (-17.85%)

BSE Healthcare

₹44,453.35

-0.32 (-144.15%)

Nifty MNC

₹28,286.60

-0.43 (-123.2%)

S&P BSE 250 SmallCap

₹6,667.16

-0.46 (-30.55%)

S&P BSE 400 MidSmallCap

₹11,741.07

-0.21 (-24.92%)

J B Chemicals & Pharmaceuticals Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in J B Chemicals & Pharmaceuticals Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
47.73%
-0.24
Foreign Institutions
17.77%
-2.89
Mutual Funds
16.27%
0.05
Retail Investors
14.88%
-1.75
Others
3.36%
36.76

J B Chemicals & Pharmaceuticals Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of J B Chemicals & Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY26,835.1168.38%0.516593,917
BUY34,960.9032.7%0.523001,051
BUY16,822.089.76%0.718367,234
NA4,551.09-4.29%1.88-34371
BUY15,765.9048.97%0.672441,515

J B Chemicals & Pharmaceuticals Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in J B Chemicals & Pharmaceuticals Ltd.

  • JB Pharma Reports Strong Q1 Growth and Dividend - 30 Jul, 2025

    JB Chemicals & Pharmaceuticals reported a 14.4% increase in Q1 FY26 net profit to ₹202 crore, with revenue up 8.9%. The Board recommended a final dividend of ₹7.00 per share.
  • Torrent Pharma to Acquire Majority Stake in J B Chemicals - 18 Jul, 2025

    Torrent Pharmaceuticals is set to acquire a majority stake in J B Chemicals & Pharmaceuticals for Rs 19,500 crore, pending regulatory approval. This acquisition will enhance Torrent's position in the Indian pharmaceutical market.
  • Torrent Pharma to Acquire Stake in JB Chemicals - 03 Jul, 2025

    Torrent Pharmaceuticals plans to acquire up to 2.41% of JB Chemicals for approximately ₹620 crore. The acquisition, subject to approvals, strengthens Torrent's position in the Indian pharmaceutical market.
  • JB Chemicals Shows Strong Growth Ahead of Torrent Control - 02 Jul, 2025

    JB Chemicals is set to gain operational control by Q4FY26, showcasing impressive growth with revenue nearly doubling from ₹2,043 crore to ₹3,918 crore and a 46% rise in net profit. The company maintains a robust RoCE of over 20%, indicating efficient capital use.

Insights on J B Chemicals & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 963.96 Cr → 1.10K Cr (in ₹), with an average increase of 13.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 145.69 Cr → 202.38 Cr (in ₹), with an average increase of 28.0% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 16.26% to 16.27% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, JBCHEPHARM stock has moved up by 3.7%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 47.84% to 47.73% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 15.14% to 14.88% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 18.30% to 17.77% in Jun 2025 quarter

About J B Chemicals & Pharmaceuticals Ltd

J B Chemicals Pharmaceuticals, founded in 1976 in Maharastra, is a global player in pharmaceutical manufacturing. It manufactures and markets a wide range of pharmaceutical formulations, herbal remedies, APIs, and agro-based products. It has subsidiaries in India and other countries and has been awarded the Certificate of Suitability to European Pharmacopoeia Monograph for Nifedipine EP from the European Directorate for Quality Medicines. It launched new products in the global market to expand its product portfolio and received approval from TGA Australia, USFDA, MCC South Africa, INVIMA Colombia, and MHRA UK. The company received the 'Most Trustworthy European Brand' by Readers Digest in cold and cough segment for the fourth consecutive year in 2003-04. It diverted into the contrast media products market during 2004-05 and entered agreements with PharmaaCare Pharmaceuticals and Ranbaxy Group for developing and marketing niche products in respective markets. It has undergone several mergers and diversifications in-order to increase its product range and profitability. More recently, it acquired a portfolio of brands from Sanzyme Private Limited and Azmarda brand from Novartis AG Switzerland. Thus, J B Chemicals Pharmaceuticals is well positioned to grow and progress further in the global pharmaceutical market.

Revenue: ₹1,093.94Cr as on June 2025 (Q1 FY26)
Net Profit: ₹202.38Cr as on June 2025 (Q1 FY26)
Listing date: 02 Feb, 1995
Chairperson Name: Ranjit Shahani.
OrganisationJ B Chemicals & Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEORanjit Shahani.
E-voting on sharesClick here to vote

Mutual Funds that own J B Chemicals & Pharmaceuticals Ltd Stock

Check out the Mutual Funds with significant holdings in J B Chemicals & Pharmaceuticals Ltd.

FAQs

What is J B Chemicals & Pharmaceuticals Ltd share price today?

J B Chemicals & Pharmaceuticals Ltd share price today stands at ₹1716.7, Open: ₹1725, Previous Close: ₹1715.5, High: ₹1729, Low: ₹1701.4, 52 Week High: ₹2030, 52 Week Low: ₹1385.75 as on .

How to buy J B Chemicals & Pharmaceuticals Ltd shares ?

To buy J B Chemicals & Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for JBCHEPHARM or J B Chemicals & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in J B Chemicals & Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of J B Chemicals & Pharmaceuticals Ltd?

Today's traded volume of J B Chemicals & Pharmaceuticals Ltd is 74.24K. Which means that 74.24K shares of J B Chemicals & Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.

What is J B Chemicals & Pharmaceuticals Ltd's market cap today?

Today's market capitalisation of J B Chemicals & Pharmaceuticals Ltd is ₹26,835.11 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of J B Chemicals & Pharmaceuticals Ltd?

J B Chemicals & Pharmaceuticals Ltd’s 52 week high is ₹2030 and 52 week low is ₹1385.75. The current share price of J B Chemicals & Pharmaceuticals Ltd is ₹1716.7, which is -15.43% down from its 52 week high and 23.88% up from its 52 week low.